Search & Analyze
Popular Searches
Neuland Laboratories Ltd.
Healthcare₹18,571.751.79%
24 Jul, 4:01 PM
CMP₹18,571.75
Mkt Cap₹23.64K Cr
P/E64.95
P/B12.62
ROE21.43%
52W High₹20,072.00
52W Low₹11,500.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
64.95
P/B Ratio
12.62
EV/EBITDA
38.84
Price/Sales
11.69
Dividend Yield (%)
0.18
EPS (TTM ₹)
283.71
Book Value (₹)
1460.31
ROE (%)
21.43
ROCE (%)
27.50
ROA (%)
14.25
EBITDA Margin (%)
28.40
Net Profit Margin (%)
17.99
Debt/Equity
0.10
Current Ratio
2.09
Interest Coverage
21.42
Asset Turnover
0.79
Working Capital/Sales
2.62
Core EBITDA Growth (%)
75.89
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 95107.66 | 119119.8 | 155858.05 | 147683.73 | 202298.54 |
| Net Sales | 95107.66 | 119119.8 | 155858.05 | 147683.73 | 202298.54 |
| Total Income | 95315.34 | 120094.62 | 157112.48 | 149734.66 | 205315.16 |
| Total Expenditure | 80845.56 | 91935.53 | 109599.1 | 115357.75 | 144848.76 |
| Operating Profit | 14469.78 | 28159.09 | 47513.38 | 34376.91 | 60466.4 |
| Depreciation | 4904.02 | 5277.74 | 5969.99 | 6554.66 | 9173.95 |
| Exceptional Items | — | — | — | 7640.36 | — |
| Profit Before Tax | 8216.25 | 21574.64 | 40143.65 | 34632.9 | 48897.71 |
| Tax | 1834.05 | 5222.88 | 10135.76 | 8622.09 | 12497.87 |
| Profit After Tax (PAT) | 6382.2 | 16351.76 | 30007.89 | 26010.81 | 36399.84 |
| EPS (₹) | 49.74 | 127.45 | 233.89 | 202.74 | 283.71 |
| Dividend Payout % | 50 | 100 | 140 | 120 | 340 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1290.05 | 1290.05 | 1290.05 | 1290.05 | 1290.05 |
| Reserves | 82760.03 | 98119.6 | 126980.43 | 151190.58 | 186157.24 |
| Shareholders Funds | 84050.08 | 99409.65 | 128270.48 | 152480.63 | 187447.29 |
| Total Debt | 23094.61 | 12150.99 | 8250.7 | 13601.01 | 19661.31 |
| Total Liabilities | 138348.84 | 157976.45 | 183256.1 | 217988.16 | 293013.77 |
| Total Assets | 138348.84 | 157976.45 | 183256.1 | 217988.16 | 293013.77 |
| Book Value / Share | 654.4021 | 774.1191 | 999.0688 | 1187.7698 | 1460.3102 |
| Assets | 138348.84 | 157976.45 | 183256.1 | 217988.16 | 293013.77 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 6038.88 | 23721.19 | 26117.67 | 31738.28 | 34668.04 |
| Investing Activities | -9551.63 | -6149.85 | -14968.68 | -29815.59 | -42373.29 |
| Financing Activities | 3772.15 | -13579.58 | -6928.18 | 2496.1 | 2097.54 |
| Net Cash Flow | 259.4 | 3991.76 | 4220.81 | 4418.79 | -5607.71 |
NEULANDLAB
₹18,571.75
+1.79%